Krismeikesari Krismeikesari. Comparative Efficacy and Safety of Finerenone, Eplerenone, and Spironolactone on Cardiorenal Outcomes in Type 2 Diabetes with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis. OAIJMR [Internet]. 2025Nov.13 [cited 2026Jan.22];6(1):1-20. Available from: https://hmpublisher.com/index.php/OAIJMR/article/view/819